Keystone Lab, a dual-CAP accredited and CLIA-certified lab based in Asheville, North Carolina, has officially added tianeptine to its in-house urine clinical toxicology menu. Keystone provides clinical and forensic toxicology testing services throughout the southeastern U.S.
Tianeptine is an atypical tricyclic antidepressant often used for addressing anxiety and irritable bowel disease. It is not approved for any use by the United States Federal Drug Administration (FDA). Tianeptine is often described as “gas-station dope” and products containing tianeptine commonly use the street names of “ZaZa” or “Tianna.” The FDA recently warned consumers to avoid purchasing or using any Neptune’s Fix products, which is illegally sold with claims to improve brain function and treat anxiety, depression, pain, opioid use disorder, and other conditions.
In addition to tianeptine and its metabolite, tianeptine metabolite MC5, Keystone has also added clozapine, N-desmethylclozapine, aripiprazole, aripiprazole metabolite OPC-3373, modafinil, diphenhydramine, loperamide, and 7OH-mitragynine to its in-house testing menu.
“The ease of obtaining products with tianeptine, combined with effects of harm, overdosing, and death has been a major obstacle for many of our addiction clinic and recovery center clients throughout North Carolina,” says James Bourland, PhD, scientific director of Keystone Lab. “By adding tianeptine testing in-house, Keystone is able to listen to its clients and provide the best service possible to their patients.”
Further reading: Smart Diaper Aids POC Urine Testing
